Jialiqi: It is planned to distribute a cash dividend of RMB 2.8 yuan every 10 shares. Jialiqi announced that it plans to distribute a cash dividend of RMB 2.8 yuan to all shareholders every 10 shares based on the company's existing total share capital of 82,975,500 shares, with a total cash dividend of RMB 23,233,100, accounting for 29.56% of the company's net profit attributable to shareholders of listed companies in the first three quarters of 2024. No bonus shares will be paid this time, and the capital reserve fund will not be converted into share capital, and the remaining undistributed profits will be carried forward to the next year.Analyst: There may be a RRR cut of 50 basis points to 100 basis points next year. Tan Yiming, chief fixed income analyst of Minsheng Securities, said that there may be a RRR cut of 50 basis points to 100 basis points next year, considering the supply pressure of government bonds, the restoration of credit supply and the provision of long-term stable low-cost funds for financial institutions.Sources: The attack on the Russian oil depot did not affect the oil transportation to Europe via Ukraine. Ukrainian industrial sources said on Wednesday that the Ukrainian attack on an oil depot in the Bryansk region of Russia at night did not affect the oil transportation to Europe via Ukraine. The Ukrainian military said on Wednesday that the warehouse was part of the "Friendship" oil export pipeline and a "fire" broke out after the air raid. The source said: "This attack has nothing to do with oil transportation because it is a facility to ensure the supply of diesel and petroleum products. Everything is going according to plan. "
The onshore RMB against the US dollar officially closed at 7.2590 at 16:30 Beijing time, down 97 points from the official closing price of the previous trading day and down 99 points from the closing price of the previous day and night.China Automotive Power Battery Industry Innovation Alliance: In November, the sales volume of power batteries in China increased by 29.7% year-on-year. According to the monthly information of power batteries in November 2024 released by China Automotive Power Battery Industry Innovation Alliance, the sales volume of power batteries and other batteries in China was 118.3GWh in November, up by 7.2% month-on-month and 40.1% year-on-year. Among them, the sales volume of power batteries was 87.8GWh, accounting for 74.2% of the total sales volume, up 10.9% from the previous month and 29.7% from the same period last year. The sales volume of other batteries was 30.5GWh, accounting for 25.8% of the total sales volume, down 2.2% from the previous month and up 82.3% year-on-year. From January to November, the cumulative sales volume of power and other batteries in China was 914.3GWh, a cumulative year-on-year increase of 42.8%. Among them, the cumulative sales of power batteries was 692.3GWh, accounting for 75.7% of the total sales, with a cumulative year-on-year increase of 27.1%; The cumulative sales volume of other batteries was 222.0GWh, accounting for 24.3% of the total sales volume, with a cumulative year-on-year increase of 132.5%.US Treasury Department: US Treasury Secretary Yellen expressed appreciation for the close communication between the Ministry of Economic Affairs of Korea and the United States after the recent events in South Korea.
Japanese Reuters's short-term non-manufacturing boom judgment index in December is 30, with the previous value of 19; Reuters's short-term judgment index of manufacturing prosperity in December was -1, with the previous value of 5.Hengrui Pharma: HRS-4729 injection was approved for clinical trial. Hengrui Pharma announced that the company and its subsidiary Fujian Sheng Di Pharmaceutical Co., Ltd. received the Notice of Approval for Clinical Trial of HRS-4729 injection approved and issued by National Medical Products Administration. The drug is a polypeptide drug independently developed, and it is a GLP-1R/GIPR/GCGR triple agonist, which is suitable for obese or overweight patients. Up to now, HRS-4729 injection has invested about 19.56 million yuan in research and development.Market information: Nissan will appoint JÉRÉMIE PAPIN as the chief financial officer on Wednesday.
Strategy guide 12-13
Strategy guide
Strategy guide
12-13
Strategy guide
12-13
Strategy guide 12-13